Pages that link to "Q53881163"

The following pages link to From Pasteur to genomics: progress and challenges in infectious diseases. (Q53881163):

Displaying 45 items.

• Emerging Vaccine Technologies (Q26783764) (← links)
• Designing vaccines for the twenty-first century society (Q27025703) (← links)
• Matrix and backstage: cellular substrates for viral vaccines (Q27025941) (← links)
• Cattle Immunized with a Recombinant Subunit Vaccine Formulation Exhibits a Trend towards Protection against Histophilus somni Bacterial Challenge (Q27334719) (← links)
• Emerging and re-emerging viruses in the era of globalisation (Q27489050) (← links)
• Delivering vaccines to the people who need them most (Q28082744) (← links)
• Computational resources in infectious disease: limitations and challenges (Q28750801) (← links)
• One-health approach as counter-measure against "autoimmune" responses in biosecurity. (Q30369133) (← links)
• Immunogenomics and systems biology of vaccines (Q33350387) (← links)
• Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo (Q33780691) (← links)
• Future trends and challenges in pathogenomics. A Foresight study (Q34360398) (← links)
• Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV) (Q34881218) (← links)
• The use of genomics in microbial vaccine development (Q34923817) (← links)
• Memory generation and maintenance of CD8+ T cell function during viral persistence (Q35031103) (← links)
• Twenty-first century vaccines (Q35137112) (← links)
• Genetics and vaccines in the era of personalized medicine (Q35548112) (← links)
• Reverse Vaccinology: Developing Vaccines in the Era of Genomics (Q35873940) (← links)
• Vaccinology at the beginning of the 21st century (Q36159950) (← links)
• Information technologies for vaccine research (Q36198676) (← links)
• The potential role of fowlpox virus in rational vaccine design (Q36600376) (← links)
• Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum (Q37009066) (← links)
• Fungal vaccines: real progress from real challenges (Q37067893) (← links)
• Advancing full length genome sequencing for human RNA viral pathogens (Q37089648) (← links)
• Host responses from innate to adaptive immunity after vaccination: molecular and cellular events (Q37392028) (← links)
• Towards Vaccine 3.0: new era opened in vaccine research and industry (Q37473508) (← links)
• Potential of immunomodulatory host defense peptides as novel anti-infectives (Q37580524) (← links)
• Emerging and re-emerging infections at the turn of the millennium (Q37670961) (← links)
• Polymer blend particles with defined compositions for targeting antigen to both class I and II antigen presentation pathways (Q37684900) (← links)
• Designing the Next Generation of Vaccines for Global Public Health (Q37891066) (← links)
• Next generation deep sequencing and vaccine design: today and tomorrow (Q38020606) (← links)
• Immunogenomics approaches for vaccine evaluation (Q38034776) (← links)
• Translational medicine policy issues in infectious disease (Q38430651) (← links)
• Vaccines, adjuvants and autoimmunity (Q38567072) (← links)
• Identification of synthetic host defense peptide mimics that exert dual antimicrobial and anti-inflammatory activities (Q41426276) (← links)
• GSIT: An integrated web-tool for identification of genomic signatures in highly similar DNA sequences (Q41725357) (← links)
• Antibacterial Properties of Flavonoids from Kino of the Eucalypt Tree, Corymbia torelliana. (Q42005688) (← links)
• Oligonucleotide-linked gold nanoparticle aggregates for enhanced sensitivity in lateral flow assays (Q42267837) (← links)
• Molecular diagnostics: the changing culture of medical microbiology (Q44425599) (← links)
• The global challenge of infectious diseases: the evolving role of the National Institutes of Health in basic and clinical research (Q45194981) (← links)
• Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity. (Q46020879) (← links)
• Surface-engineered polyelectrolyte multilayer capsules: synthetic vaccines mimicking microbial structure and function (Q49030612) (← links)
• Protection against neonatal enteric colibacillosis employing E. Coli-derived outer membrane vesicles in formulation and without vitamin D3. (Q55262720) (← links)
• Genetics and Vaccinology (Q56451891) (← links)
• Targeting Difficult Protein-Protein Interactions with Plain and General Computational Approaches (Q58691534) (← links)
• A 21st century view of infection control in everyday settings: moving from the Germ Theory of Disease to the Microbial Theory of Health (Q95651498) (← links)